DE701094C - Process for the production of an anterior pituitary hormone preparation - Google Patents

Process for the production of an anterior pituitary hormone preparation

Info

Publication number
DE701094C
DE701094C DE1937I0056946 DEI0056946D DE701094C DE 701094 C DE701094 C DE 701094C DE 1937I0056946 DE1937I0056946 DE 1937I0056946 DE I0056946 D DEI0056946 D DE I0056946D DE 701094 C DE701094 C DE 701094C
Authority
DE
Germany
Prior art keywords
anterior pituitary
production
pituitary hormone
hormone preparation
weight
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
DE1937I0056946
Other languages
German (de)
Inventor
Dr Hermann Friedrich
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
IG Farbenindustrie AG
Original Assignee
IG Farbenindustrie AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by IG Farbenindustrie AG filed Critical IG Farbenindustrie AG
Priority to DE1937I0056946 priority Critical patent/DE701094C/en
Application granted granted Critical
Publication of DE701094C publication Critical patent/DE701094C/en
Expired legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22Hormones
    • A61K38/24Follicle-stimulating hormone [FSH]; Chorionic gonadotropins, e.g. HCG; Luteinising hormone [LH]; Thyroid-stimulating hormone [TSH]

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Endocrinology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Reproductive Health (AREA)
  • Immunology (AREA)
  • Zoology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)

Description

Verfahren zur Herstellung eines Hypophysenvorderlappenhormonpräparates Das Hauptpatent 672 804 betrifft ein Verfahren zur Herstellung eines Hypophysenvorderlappenhormonpräparates, bei dem man Suspensionen des Hormons in physiologisch unschädlichen Ölen unter Zusatz von Wollfett herstellt.Process for the production of an anterior pituitary hormone preparation The main patent 672 804 relates to a process for the production of an anterior pituitary lobe hormone preparation, in which one suspensions of the hormone in physiologically harmless oils with additives of wool fat.

Es hat sich gezeigt, daß im Laufe der Zeit eine gewisse Abnahme der physiologischen Wirkung des Hypophysenvorderlappenhorm,ons in solchen Suspensionen eintritt. Diese Feststellung war überraschend, da bekannt war, daß das Hypophysenvorderlappenhormon in trockener Form haltbar ist.It has been shown that over time a certain decrease in Physiological effect of the anterior pituitary hormone in such suspensions entry. This finding was surprising since it was known that the anterior pituitary hormone is stable in dry form.

Es wurde nun gefunden, daß man den Haltbarkeitsverlust dadurch weitgehend ausschalten kann, wenn man den gemäß dem Verfahren des Hauptpatents 672804 erhältlichen Suspensionen des gonadotropen Hypophysenvorderlappenhormons öllösliche Stoffe zusetzt, die oxydationsverhütend wirken. It has now been found that the loss of shelf life can largely be eliminated by adding oil-soluble substances which prevent oxidation to the suspensions of the gonadotropic anterior pituitary hormone obtainable according to the method of main patent 672804.

Als Zusätze kommen die üblichen oxydationsverhütenden Stoffe, insbesondere solche phenolischer Art, wie Hydrochinon, Resorcin, Phenol und Pyrogallol, in Frage. Der mengenmäßige Zusatz dieser Stoffe kann weitgehend schwanken, Im allgemeinen genügt ein o,2%iger Zusatz an dem oxydationsverhütenden Stoff, berechnet auf die Gesamtmenge der Suspension.The usual anti-oxidation substances, in particular, are used as additives phenolic types such as hydroquinone, resorcinol, phenol and pyrogallol are in question. The amount of these substances added can vary widely, in general an o, 2% addition of the antioxidant substance is sufficient, calculated on the basis of the Total amount of suspension.

Es hat sich gezeigt, daß die nach der Erfindung hergestellten Hypophysenvorderlappenhormonpräparate besonders haltbar sind. Zum Beispiel hat eine Suspension des Hormons in einer Lanolin-Olivenöl-Mischung, der o,2 % Hydrochinon oder Resorcin zugesetzt wurde, nach mehrmonatiger Aufbewahrung bei Zimmertemperatur praktisch nichts an Wirksamkeit verloren.It has been shown that the anterior pituitary hormone preparations prepared according to the invention are particularly durable. For example, a suspension of the hormone in a mixture of lanolin and olive oil, to which o, 2% hydroquinone or resorcinol was added, after several months of storage practically none of its effectiveness lost at room temperature.

Beispiel t In too Gewichtsteilen Sesamöl löst man unter Erwärmen to Gewichtsteile wasserfreies Lanolin und 0,2 Gewichtsteile Hydrochinon. Nach dem Abkühlen wird dieses Gemisch mit einer solchen Menge eines gonadotropen Hypophysenvorderlappenhormonpräparates verrieben, daß i ccm der erhaltenen Suspension i oo Ratteneinheiten enthält. Man benötigt zu diesem Zwecke je nach der Reinheit des angewandten Hypophysenvorderlappenhormons o,2 bis i Gewichtsteil. Die hergestellte Suspension ist haltbar und reizlos.Example t In too parts by weight of sesame oil is dissolved by heating to Part by weight of anhydrous lanolin and 0.2 part by weight of hydroquinone. After cooling down becomes this mixture with such an amount of a gonadotropic anterior pituitary hormone preparation triturated so that 1 cc of the suspension obtained contains 100 rat units. Man required for this purpose depending on the purity of the anterior pituitary lobe hormone used 0.2 to i part by weight. The suspension produced is durable and non-irritating.

Beispiel e Man stellt aus i Gewichtsteil eines hochgereinigten Hypophysenvorderlappenhormonpräparates, das ioo ooo Ratteneinheiten in einem Gewichtsteil enthält, ferner aus o,2 Gewichtsteilen Resorcin, i o Gewichtsteilen Lanolin und t oo Gewichtsteilen Olivenöl eine Suspension her. Diese setzt schwer ab, ist halt bar und reizlos und kann injiziert werden.Example e From i part by weight of a highly purified anterior pituitary hormone preparation, which contains 1,000,000 rat units in one part by weight, and 0.2 parts by weight Resorcinol, 10 parts by weight of lanolin and 10 parts by weight of olive oil are a suspension here. This is difficult to settle, is permanent and irritation-free and can be injected.

Claims (2)

PATENTANSPRÜCHE: i. Verfahren zur Herstellung eines Hypophysenvorderlappenhormonpräparates gemäß Patent 672 8o4, dadurch gekennzeichnet, daß den nach dem Verfahren des Patents 672 8o4 hergestellten Suspensionen des Hormons öllösliche oxydationsverhütende Stoffe zugesetzt werden. PATENT CLAIMS: i. Process for the production of an anterior pituitary hormone preparation according to patent 672 8o4, characterized in that oil-soluble antioxidant substances are added to the suspensions of the hormone produced according to the process of patent 672 8o4. 2. Verfahren nach Anspruch i, dadurch gekennzeichnet, daß als oxydationsverhütende Stoffe Phenole zur Anwendung gelangen.2. The method according to claim i, characterized in that as Oxidation-preventing substances phenols are used.
DE1937I0056946 1937-01-23 1937-01-23 Process for the production of an anterior pituitary hormone preparation Expired DE701094C (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
DE1937I0056946 DE701094C (en) 1937-01-23 1937-01-23 Process for the production of an anterior pituitary hormone preparation

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE1937I0056946 DE701094C (en) 1937-01-23 1937-01-23 Process for the production of an anterior pituitary hormone preparation

Publications (1)

Publication Number Publication Date
DE701094C true DE701094C (en) 1941-01-08

Family

ID=7194474

Family Applications (1)

Application Number Title Priority Date Filing Date
DE1937I0056946 Expired DE701094C (en) 1937-01-23 1937-01-23 Process for the production of an anterior pituitary hormone preparation

Country Status (1)

Country Link
DE (1) DE701094C (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE940133C (en) * 1949-10-18 1956-03-08 Heinrich Schmidt Process for obtaining highly effective organ extracts

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE940133C (en) * 1949-10-18 1956-03-08 Heinrich Schmidt Process for obtaining highly effective organ extracts

Similar Documents

Publication Publication Date Title
DE701094C (en) Process for the production of an anterior pituitary hormone preparation
AT129939B (en) Process for the production of a wound ointment.
DE865100C (en) Process for the production of water-in-oil emulsions such as margarine
Logemann et al. Über die Spezifizität der Antipermeabilitätsaktivität des Benzoylcarbinols und seiner Derivate (Zugleich IV. Mitteil. über einige den Nebennierenrinden-Hormonen verwandte Verbindungen)
DE463792C (en) Process for the production of a cold mixture
DE899294C (en) Process for the preparation of a spray composition containing dinitroorthocresol
DE606025C (en) Wetting agent for mercerising liquors
DE416982C (en) Method of killing bed bugs
DE676171C (en) Fragrance mixture
Sanada Studien über den kolloid= osmotischen Druck des Gewebseiweisses III. Mitteilung: Gewebseiweiss und dessen kolloid-osmotische Druck bei Leberschädigung
DE634626C (en) Hair care products
DE672804C (en) Process for the production of oily suspensions of the anterior pituitary lobe hormone
DE585972C (en) Process for the refinement of edible fats
AT203152B (en) Process for the preparation of highly effective oily injection solutions of esters of testosterone
DE748867C (en) Process for making photographic emulsions
AT103221B (en) Process for the production of iron leather.
DE486914C (en) Process for the production of a preparation from ovaries and similar organs
DE688921C (en) Process for obtaining an active ingredient which increases leukocyte formation from red bone marrow
DE643062C (en) Process for the production of durable derris root extracts that can be emulsified with water
Tropp et al. Sphingomyelin bei Niemann-Pickscher Krankheit.
DE403050C (en) Process for the preparation of glycerol benzyl ether
DE870320C (en) Process for the production of a powder preparation for the treatment of oxyuriasis
DE916109C (en) Process for obtaining highly effective adrenal cortical extracts
DE760326C (en) Process for the preparation of diesters of oxy-ª ‡, ª ‰ -diaethyl-ª ‡, ª ‰ -diarylaethanes
DE663970C (en) Process for obtaining effective anterior pituitary lobe extracts